← Leaderboards
Peter B Cserhalmi-Friedman
Columbia University Health Sciences
$246,123
Attributed
$246,123
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$246,123 · 2
By mechanism
K01$123,498 · 1
R03$122,625 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Wendy K Chung$27,581,365
- Anne O'Donnell-Luria$13,314,675
- Angela M Christiano$35,497,344
- Hashim M Al-Hashimi$12,988,894
- Simone Sanna-Cherchi$8,907,719
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureBasement MembraneCollagenEpidermolysis BullosaFibroblastsGene TherapyKeratinocyteMessenger RnaModel Design /DevelopmentRibozymesAlternatives To Animals In ResearchGene ExpressionBiological ModelsBiotherapeutic AgentDrug Design /Synthesis /ProductionElectron MicroscopySkinGene TargetingMorphologyGenetic DisorderHuman Genetic Material TagHuman Therapy EvaluationImmunofluorescence TechniqueBioengineering /Biomedical Engineering
Grant awards (4)
Gene therapy model for dystrophic epidermolysis bullosa$40,875
R03 · FY2004 · AR
Gene therapy model for dystrophic epidermolysis bullosa$40,875
R03 · FY2003 · AR
Development of Model for Gene Therapy in DDEB$123,498
K01 · FY2001 · AR
Gene therapy model for dystrophic epidermolysis bullosa$40,875
R03 · FY2001 · AR